New drug hailed a 'game changer' for cancer patients

New drug hailed a 'game changer' for cancer patients
 

Nivolumab was hailed a potential "game changer" after it was found to extend the lives of relapsed patients who had run out of therapy options.
After a year of treatment, 36% of trial patients treated with the drug were still alive compared with 17% of those given standard chemotherapy.
Patients with advanced head and neck cancers resistant to chemotherapy are notoriously difficult to treat and generally survive less than six months.
Trial participants treated with nivolumab typically survived for 7.5 months, and some for longer. Middle range survival for patients on chemotherapy... read more

 
9 October 2016 in Regional West, Views: 32
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31